Lack of association between IL-4 -588C>T polymorphism and NHL susceptibility

Abstract

The relationship of non-Hodgkin’s lymphoma (NHL) with the presence of interleukin-4 genetic polymorphism -588C>T has been reported with inconsistent results. The objective of this study was to quantitatively evaluate the association between -588C>T polymorphism and NHL susceptibility. Two investigators independently searched Medline and the Cochrane Library up to September 20, 2013. Pooled odds ratio and 95 % confidence interval were calculated using a fixed or random effects model. Statistical analysis was performed with Review Manage 5.0 and Stata 11. Of the six case-control studies selected for this meta-analysis, a total of 1,909 NHL cases and 1,834 controls were included. The combined results based on all studies suggested that -588C>T was not associated with NHL risk under all genetic models. When stratifying for race, no noteworthy associations were observed in mixed populations or Caucasians. This meta-analysis suggests that IL-4 -588C>T polymorphism might not be a risk factor for NHL risk. However, further well-designed studies are required to confirm our findings.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Rosenwald A, Staudt LM. Clinical translation of gene expression profiling in lymphomas and leukemias. Semin Oncol. 2002;29:258–63.

    Article  PubMed  Google Scholar 

  2. 2.

    Gao SM, Yang JJ, Chen CQ, Chen JJ, Ye LP, Wang LY, et al. Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. J Exp Clin Cancer Res. 2012;31:27.

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99:4283–97.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Wen-Li Z, Jian W, Yan-Fang T, Xing F, Yan-Hong L, Xue-Ming Z, et al. Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines. J Exp Clin Cancer Res. 2012;31:92.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Huang Y, Hu J, Zheng J, Li J, Wei T, Zheng Z, et al. Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin. J Exp Clin Cancer Res. 2012;31:48.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Zhang H, Xu Y, Zhang Z, Liu R, Ma B. Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis. BMC Immunol. 2012;13:14.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Zhang HT, Xu Y, Zhang ZH, Li L. Meta-analysis of epidemiological studies demonstrates significant association of PTGS2 polymorphism rs689470 and no significant association of rs20417 with prostate cancer. Genet Mol Res. 2012;11(2):1642–50.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205–18.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Zhang H, Ma H, Xu Y, Li L. Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis. PLoS ONE. 2013;8:e58170.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Zhang H, Ma H, Li L, Zhang Z, Xu Y. Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis. PLoS One. 2013;8:e69366.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Zhang H, Li L, Xu Y. CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis. PLoS One. 2013;8:e68634.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Serefoglou Z, Yapijakis C, Nkenke E, Vairaktaris E. Genetic association of cytokine DNA polymorphisms with head and neck cancer. Oral Oncol. 2008;44:1093–9.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy. 1995;25:74–8.

    Article  PubMed  Google Scholar 

  14. 14.

    Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, et al. Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun. 2002;3:107–9.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Scarel-Caminaga RM, Trevilatto PC, Souza AP, Brito RB, Line SR. Frequencies of the -330 (T/G) IL-2 and -590(T/C) IL-4 gene polymorphisms in a population from southeastern Brazil. Eur J Immunogenet. 2002;9:293–6.

    Article  Google Scholar 

  16. 16.

    Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M. The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int. 2005;26:48–51.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Andrie E, Michos A, Kalampoki V, Pourtsidis A, Moschovi M, Polychronopoulou S, et al. Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol. 2009;83:334–42.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Wong HL, Breen EC, Pfeiffer RM, Aissani B, Martinson JJ, Margolick JB, et al. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study. AIDS. 2010;24:1025–33.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, Severson RK, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res. 2006;66:9771–80.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood. 2006;107:4101–8.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Zhang H, Qi C, Li L, Luo F, Xu Y. Clinical significance of NUCB2 mRNA expression in prostate cancer. J Exp Clin Cancer Res. 2013;32:56.

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Zhang H, Qi C, Wang A, Li L, Xu Y. High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer. Tumor Biol. 2013. doi:10.1007/s13277-013-1268-z.

    Google Scholar 

  23. 23.

    Zhang H, Qi C, Wang A, Yao B, Li L, Wang Y, et al. Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer. J Exp Clin Cancer Res. 2013;32:77.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Gao SM, Xing CY, Chen CQ, Lin SS, Dong PH, Yu FJ. miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level. J Exp Clin Cancer Res. 2011;30:110.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Mhaidat NM, Alshogran OY, Khabour OF, Alzoubi KH, Matalka II, Haddadin WJ, et al. Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin’s Lymphoma. J Exp Clin Cancer Res. 2011;30:68.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Kowalska M, Tajer J, Chechlinska M, Fuksiewicz M, Kotowicz B, Syczewska M, et al. Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma. Tumor Biol. 2012;33(5):1733–8.

    CAS  Article  Google Scholar 

  27. 27.

    Yang J, Wang S, Zhao G, Sun B. Effect of chemokine receptors CCR7 on disseminated behavior of human T cell lymphoma: clinical and experimental study. J Exp Clin Cancer Res. 2011;30:51.

    Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Pei JH, Luo SQ, Zhong Y, Chen JH, Xiao HW, Hu WX. The association between non-Hodgkin lymphoma and methylation of p73. Tumor Biol. 2011;32(6):1133–8.

    CAS  Article  Google Scholar 

  29. 29.

    Diggs DL, Harris KL, Rekhadevi PV, Ramesh A. Tumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in ApcMin mouse model of colon cancer. Tumor Biol. 2012;33(4):1255–60.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Yanhua Jing or Chengjin Hu.

Additional information

Zihan Sun and Jing Pei contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sun, Z., Pei, J., Cui, F. et al. Lack of association between IL-4 -588C>T polymorphism and NHL susceptibility. Tumor Biol. 35, 4897–4900 (2014). https://doi.org/10.1007/s13277-014-1642-5

Download citation

Keywords

  • NHL
  • IL-4
  • Association
  • Polymorphism
  • Meta-analysis